Literature DB >> 8775462

Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.

R N Germain1.   

Abstract

Major histocompatibility complex class II molecules are heterodimeric type I integral membrane glycoproteins whose primary function is the capture of fragments of antigen in the endocytic pathway, and the presentation of these peptides to CD4+ alpha beta TCR-bearing T cells. The biochemical features of the class II peptide binding domain optimize it for this function by allowing interaction with denatured proteins prior to extensive degradation in endosomes and lysosomes. These same properties pose problems for alpha beta heterodimer assembly, avoidance of non-productive interactions with self-proteins, intracellular transport and dimer stability. This review discusses how coevolution of alpha and beta chain binding domain polymorphism and the extrinsic control of binding site function by invariant chain occupancy deal with these problems and permit the efficient functioning of the class II presentation system.

Mesh:

Substances:

Year:  1995        PMID: 8775462     DOI: 10.1006/smim.1995.0041

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  8 in total

1.  Function-related regulation of the stability of MHC proteins.

Authors:  A Simon; Z s Dosztányi; E Rajnavölgyi; I Simon
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

2.  Role of the major histocompatibility complex class II transmembrane region in antigen presentation and intracellular trafficking.

Authors:  Yelena A Barabanova; Hee-Kap Kang; Jinjong Myoung; Bongsu Kang; Gail A Bishop; Byung S Kim
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

3.  In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.

Authors:  L Lightstone; R Hargreaves; G Bobek; M Peterson; G Aichinger; G Lombardi; R Lechler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

4.  Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP).

Authors:  G Zhong; F Castellino; P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

5.  I-Ag7 is subject to post-translational chaperoning by CLIP.

Authors:  Cornelia H Rinderknecht; Ning Lu; Oliver Crespo; Phi Truong; Tieying Hou; Nan Wang; Narendiran Rajasekaran; Elizabeth D Mellins
Journal:  Int Immunol       Date:  2010-06-13       Impact factor: 4.823

6.  Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein.

Authors:  G Zhong; P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

7.  Alteration of a single hydrogen bond between class II molecules and peptide results in rapid degradation of class II molecules after invariant chain removal.

Authors:  S Ceman; S Wu; T S Jardetzky; A J Sant
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

8.  Integrative Analysis of HTNV Glycoprotein Derived MHC II Epitopes by In Silico Prediction and Experimental Validation.

Authors:  Hao Sun; Zhenhua Lu; Guoyun Xuan; Ning Liu; Tianhu Wang; Yang Liu; Mingfu Lan; Jiahao Xu; Yuancai Feng; Shuang Xu; Yuchen Lu; Baozeng Sun; Jinpeng Zhang; Xiyang Zhang; Yuanjie Sun; Shuya Yang; Yun Zhang; Yusi Zhang; Linfeng Cheng; Dongbo Jiang; Kun Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-07-19       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.